{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:45:04Z","timestamp":1791049504881,"version":"4.1.0"},"reference-count":42,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.9588","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T23:53:10Z","timestamp":1651276390000},"page":"e229588","source":"Crossref","is-referenced-by-count":43,"title":["Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration"],"prefix":"10.1001","volume":"5","author":[{"given":"Ignacio","family":"Ill\u00e1n-Gala","sequence":"first","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Atlantic Fellow for Equity in Brain Health at the University of California, San Francisco, Department of Neurology, University of California, San Francisco"},{"name":"Centro de Investigaci\u00f3n en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Nigro","sequence":"additional","affiliation":[{"name":"Center for Neurodegenerative Diseases and the Aging Brain, Department of Clinical Research in Neurology, University of Bari Aldo Moro, Pia Fondazione Cardinale G. Panico, Tricase, Lecce, Italy"},{"name":"Institute of Nanotechnology, National Research Council, Lecce, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawren","family":"VandeVrede","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Falg\u00e0s","sequence":"additional","affiliation":[{"name":"Atlantic Fellow for Equity in Brain Health at the University of California, San Francisco, Department of Neurology, University of California, San Francisco"},{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary W.","family":"Heuer","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e8lia","family":"Painous","sequence":"additional","affiliation":[{"name":"Parkinson\u2019s Disease & Movement Disorders Unit, Hospital Cl\u00ednic, Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer, CIBERNED, European Reference Network for Rare Neurological Diseases, Institut de Neuroci\u00e8ncies, Universitat de Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslau","family":"Compta","sequence":"additional","affiliation":[{"name":"Parkinson\u2019s Disease & Movement Disorders Unit, Hospital Cl\u00ednic, Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer, CIBERNED, European Reference Network for Rare Neurological Diseases, Institut de Neuroci\u00e8ncies, Universitat de Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Mart\u00ed","sequence":"additional","affiliation":[{"name":"Parkinson\u2019s Disease & Movement Disorders Unit, Hospital Cl\u00ednic, Instituto de Investigaciones Biom\u00e9dicas August Pi i Sunyer, CIBERNED, European Reference Network for Rare Neurological Diseases, Institut de Neuroci\u00e8ncies, Universitat de Barcelona, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Montal","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Pagonabarraga","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain"},{"name":"Movement Disorders Unit, Sant Pau Hospital and Biomedical Research Institute, Barcelona, Spain"},{"name":"Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain"},{"name":"Movement Disorders Unit, Sant Pau Hospital and Biomedical Research Institute, Barcelona, Spain"},{"name":"Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lle\u00f3","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Fortea","sequence":"additional","affiliation":[{"name":"Sant Pau Memory Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"},{"name":"Centro de Investigaci\u00f3n en Red-Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Logroscino","sequence":"additional","affiliation":[{"name":"Center for Neurodegenerative Diseases and the Aging Brain, Department of Clinical Research in Neurology, University of Bari Aldo Moro, Pia Fondazione Cardinale G. Panico, Tricase, Lecce, Italy"},{"name":"Department of Basic Medicine, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Quattrone","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences, Institute of Neurology, Magna Graecia University, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Quattrone","sequence":"additional","affiliation":[{"name":"Neuroimaging Research Unit, Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy"},{"name":"Neuroimaging Research Unit, Institute of Molecular Bioimaging and Physiology, National Research Council, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Perry","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Gorno-Tempini","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard J.","family":"Rosen","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea T.","family":"Grinberg","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Spina","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"La Joie","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil D.","family":"Rabinovici","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Miller","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C.","family":"Rojas","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Seeley","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Boxer","sequence":"additional","affiliation":[{"name":"Memory and Aging Center, Department of Neurology, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"key":"zoi220292r1","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1146\/neuro.2001.24.issue-1","article-title":"Neurodegenerative tauopathies.","volume":"24","author":"Lee","year":"2001","journal-title":"Annu Rev Neurosci"},{"issue":"4","key":"zoi220292r2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","article-title":"Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease.","volume":"3","author":"Goedert","year":"1989","journal-title":"Neuron"},{"issue":"4","key":"zoi220292r3","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s13311-020-00888-5","article-title":"Four-repeat tauopathies: current management and future treatments.","volume":"17","author":"VandeVrede","year":"2020","journal-title":"Neurotherapeutics"},{"key":"zoi220292r4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/jnc.13588","article-title":"Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies.","volume":"138","author":"Mackenzie","year":"2016","journal-title":"J Neurochem"},{"issue":"2","key":"zoi220292r5","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ana.v70.2","article-title":"Clinicopathological correlations in corticobasal degeneration.","volume":"70","author":"Lee","year":"2011","journal-title":"Ann Neurol"},{"issue":"2","key":"zoi220292r6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.neurobiolaging.2006.09.019","article-title":"Voxel-based morphometry in autopsy proven PSP and CBD.","volume":"29","author":"Josephs","year":"2008","journal-title":"Neurobiol Aging"},{"issue":"12","key":"zoi220292r7","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1093\/brain\/awx254","article-title":"Clinicopathological correlations in behavioural variant frontotemporal dementia.","volume":"140","author":"Perry","year":"2017","journal-title":"Brain"},{"key":"zoi220292r8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","article-title":"Progressive supranuclear palsy. a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia.","volume":"10","author":"Steele","year":"1964","journal-title":"Arch Neurol"},{"issue":"1","key":"zoi220292r9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/archneur.1968.00470310034003","article-title":"Corticodentatonigral degeneration with neuronal achromasia.","volume":"18","author":"Rebeiz","year":"1968","journal-title":"Arch Neurol"},{"issue":"1","key":"zoi220292r10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1212\/01.wnl.0000191307.69661.c3","article-title":"Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP.","volume":"66","author":"Josephs","year":"2006","journal-title":"Neurology"},{"issue":"14","key":"zoi220292r11","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/mds.26054","article-title":"The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.","volume":"29","author":"Respondek","year":"2014","journal-title":"Mov Disord"},{"issue":"1","key":"zoi220292r12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"issue":"Pt 10","key":"zoi220292r13","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1093\/brain\/awu223","article-title":"The evolution of primary progressive apraxia of speech.","volume":"137","author":"Josephs","year":"2014","journal-title":"Brain"},{"issue":"Pt 9","key":"zoi220292r14","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1093\/brain\/aww159","article-title":"Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer\u2019s disease.","volume":"139","author":"Ch\u00e9telat","year":"2016","journal-title":"Brain"},{"issue":"3","key":"zoi220292r15","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/ana.v81.3","article-title":"Typical and atypical pathology in primary progressive aphasia variants.","volume":"81","author":"Spinelli","year":"2017","journal-title":"Ann Neurol"},{"issue":"12","key":"zoi220292r16","doi-asserted-by":"publisher","first-page":"e1047","DOI":"10.1212\/WNL.0000000000005163","article-title":"Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration.","volume":"90","author":"Seo","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"zoi220292r17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jalz.2019.06.4956","article-title":"New directions in clinical trials for frontotemporal lobar degeneration: methods and outcome measures.","volume":"16","author":"Boxer","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"7","key":"zoi220292r18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S1474-4422(17)30157-6","article-title":"Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches.","volume":"16","author":"Boxer","year":"2017","journal-title":"Lancet Neurol"},{"issue":"7","key":"zoi220292r20","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/mds.27038","article-title":"Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be?","volume":"32","author":"Whitwell","year":"2017","journal-title":"Mov Disord"},{"issue":"6","key":"zoi220292r21","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mds.26987","article-title":"Clinical diagnosis of progressive supranuclear palsy: the Movement Disorder Society criteria.","volume":"32","author":"H\u00f6glinger","year":"2017","journal-title":"Mov Disord"},{"issue":"6","key":"zoi220292r22","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mds.v35.6","article-title":"Automated MRI classification in progressive supranuclear palsy: a large international cohort study.","volume":"35","author":"Nigro","year":"2020","journal-title":"Mov Disord"},{"issue":"20","key":"zoi220292r23","doi-asserted-by":"publisher","first-page":"11050","DOI":"10.1073\/pnas.200033797","article-title":"Measuring the thickness of the human cerebral cortex from magnetic resonance images.","volume":"97","author":"Fischl","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"zoi220292r24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neuroimage.2015.02.065","article-title":"Bayesian segmentation of brainstem structures in MRI.","volume":"113","author":"Iglesias","year":"2015","journal-title":"Neuroimage"},{"issue":"11","key":"zoi220292r25","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1001\/archneur.58.11.1803","article-title":"Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick\u2019s Disease.","volume":"58","author":"McKhann","year":"2001","journal-title":"Arch Neurol"},{"issue":"1","key":"zoi220292r26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-008-0460-5","article-title":"Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations.","volume":"117","author":"Mackenzie","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"1","key":"zoi220292r27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","article-title":"Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update.","volume":"119","author":"Mackenzie","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"20","key":"zoi220292r28","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"zoi220292r29","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1212\/WNL.0000000000002373","article-title":"Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage.","volume":"86","author":"Ranasinghe","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"zoi220292r30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1001\/archneur.63.1.81","article-title":"Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.","volume":"63","author":"Boxer","year":"2006","journal-title":"Arch Neurol"},{"issue":"3","key":"zoi220292r31","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"11","key":"zoi220292r32","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v098.i11","article-title":"cutpointr: Improved estimation and validation of optimal cutpoints in R.","volume":"98","author":"Thiele","year":"2021","journal-title":"J Stat Softw"},{"key":"zoi220292r33","doi-asserted-by":"publisher","DOI":"10.1002\/mds.v37.4","article-title":"Brainstem biomarkers of clinical variant and pathology in progressive supranuclear palsy.","author":"Grijalva","year":"2021","journal-title":"Mov Disord"},{"issue":"1","key":"zoi220292r34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00401-012-0983-7","article-title":"CSF biomarkers cutoffs: the importance of coincident neuropathological diseases.","volume":"124","author":"Toledo","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"19","key":"zoi220292r35","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1212\/WNL.0000000000003305","article-title":"Progression of brain atrophy in PSP and CBS over 6 months and 1 year.","volume":"87","author":"Dutt","year":"2016","journal-title":"Neurology"},{"issue":"1","key":"zoi220292r36","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1148\/radiol.2453061703","article-title":"MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.","volume":"246","author":"Quattrone","year":"2008","journal-title":"Radiology"},{"issue":"14","key":"zoi220292r37","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/mds.24968","article-title":"Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy.","volume":"27","author":"Massey","year":"2012","journal-title":"Mov Disord"},{"issue":"3","key":"zoi220292r38","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.1290","article-title":"Diagnostic utility of measuring cerebral atrophy in the behavioral variant of frontotemporal dementia and association with clinical deterioration.","volume":"4","author":"Ill\u00e1n-Gala","year":"2021","journal-title":"JAMA Netw Open"},{"key":"zoi220292r39","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.102152","article-title":"Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.","volume":"25","author":"Whitwell","year":"2020","journal-title":"Neuroimage Clin"},{"issue":"3","key":"zoi220292r40","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1001\/jamaneurol.2019.4347","article-title":"Diagnosis across the spectrum of progressive supranuclear palsy and corticobasal syndrome.","volume":"77","author":"Jabbari","year":"2020","journal-title":"JAMA Neurol"},{"issue":"5","key":"zoi220292r41","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration.","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"zoi220292r42","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1016\/j.parkreldis.2015.09.041","article-title":"The phenotypic spectrum of progressive supranuclear palsy.","volume":"22","author":"Respondek","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"zoi220292r19","unstructured":"US Food and Drug Administration. Context of use. FDA. July 7, 2021. Accessed September 6, 2021. https:\/\/www.fda.gov\/drugs\/biomarker-qualification-program\/context-use"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2791726\/illngala_2022_oi_220292_1652890384.67883.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T15:00:29Z","timestamp":1653490829000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2791726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.9588","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]}}}